Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis
Preprint
Abstract
Myofibroblast differentiation, essential for driving extracellular matrix synthesis in pulmonary fibrosis, requires increased glycolysis. While glycolytic cells must export lactate, the contributions of lactate transporters to myofibroblast differentiation are unknown. In this study, we investigated how MCT1 and MCT4, key lactate transporters, influence myofibroblast differentiation and experimental pulmonary fibrosis. Our findings reveal that inhibiting MCT1 or MCT4 reduces TGFβ-stimulated pulmonary myofibroblast differentiation in vitro and decreases bleomycin-induced pulmonary fibrosis in vivo . Through comprehensive metabolic analyses, including bioenergetics, stable isotope tracing, metabolomics, and imaging mass spectrometry in both cells and mice, we demonstrate that inhibiting lactate transport enhances oxidative phosphorylation, reduces reactive oxygen species production, and diminishes glucose metabolite incorporation into fibrotic lung regions. Furthermore, we introduce VB253, a novel MCT4 inhibitor, which ameliorates pulmonary fibrosis in both young and aged mice, with comparable efficacy to established antifibrotic therapies. These results underscore the necessity of lactate transport for myofibroblast differentiation, identify MCT1 and MCT4 as promising pharmacologic targets in pulmonary fibrosis, and support further evaluation of lactate transport inhibitors for patients for whom limited therapeutic options currently exist. SUMMARY: Small molecule inhibitors of lactate transporters, including the novel MCT4 inhibitor VB253, reprogram fibroblast metabolism to prevent myofibroblast differentiation and decrease bleomycin-induced pulmonary fibrosis.Keywords
All Related Versions
- Published version: Science Translational Medicine, 18 (848), eads2673.
This publication has 84 references indexed in Scilit:
- Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary FibrosisLung, 2022
- The pyruvate-lactate axis modulates cardiac hypertrophy and heart failureCell Metabolism, 2021
- Quantitative Fluxomics of Circulating MetabolitesCell Metabolism, 2020
- Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer CellsCell Reports, 2018
- Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studiesMetabolomics, 2018
- The Science and Translation of Lactate Shuttle TheoryCell Metabolism, 2018
- Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP SynthaseCell, 2017
- Hypoxia-Mediated Increases in l -2-hydroxyglutarate Coordinate the Metabolic Response to Reductive StressCell Metabolism, 2015
- Targeting of cancer energy metabolismMolecular Nutrition & Food Research, 2009
- Correction of13C Mass Isotopomer Distributions for Natural Stable Isotope AbundanceJournal of Mass Spectrometry, 1996